{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:27:11Z","timestamp":1724804831047},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,27]]},"DOI":"10.7759\/cureus.67955","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T18:00:56Z","timestamp":1724781656000},"source":"Crossref","is-referenced-by-count":0,"title":["Outcomes of Watch-and-Wait Versus Abdominoperineal Resection in Lower Rectal Adenocarcinoma Post Neoadjuvant Therapy: An Iraqi Cohort Study"],"prefix":"10.7759","author":[{"given":"Aqeel S","family":"Mahmood","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osama","family":"Jalal Fakhir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haider A","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manwar","family":"Abdulelah Alnaqqash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahseen","family":"Alrubaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wieeam","family":"Abdulfattah Saleh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed A","family":"Alkadir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Zuhair Alsammarraie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Forat","family":"Yahya Mohsin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed A","family":"Shakir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yesor","family":"Jamal Albadri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcol.2019.06.003","article-title":"Rectal cancer and chemoradiation in Iraq: systematic review and meta-analysis","volume":"39","author":"Alshewered AS","year":"2019","unstructured":"Alshewered AS, Al-Naqqash MA. Rectal cancer and chemoradiation in Iraq: systematic review and meta-analysis. J Coloproctol. 2019, 39:309-18. 10.1016\/j.jcol.2019.06.003","journal-title":"J Coloproctol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.32007\/jfacmedbagdad.6321825","article-title":"A comparative study of colorectal cancer based on patient\u2019s age","volume":"63","author":"Dhahir NK","year":"2021","unstructured":"Dhahir NK, Noaman AA. A comparative study of colorectal cancer based on patient\u2019s age. J Fac Med Baghdad. 2021, 63:70-3. 10.32007\/jfacmedbagdad.6321825","journal-title":"J Fac Med Baghdad"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5144\/0256-4947.2022.252","article-title":"Trends in colorectal cancer in Iraq over two decades: incidence, mortality, topography and morphology","volume":"42","author":"Ibrahem S","year":"2022","unstructured":"Ibrahem S, Ahmed H, Zangana S. Trends in colorectal cancer in Iraq over two decades: incidence, mortality, topography and morphology. Ann Saudi Med. 2022, 42:252-61. 10.5144\/0256-4947.2022.252","journal-title":"Ann Saudi Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.852927","article-title":"Molecular network of colorectal cancer and current therapeutic options","volume":"12","author":"Huang Z","year":"2022","unstructured":"Huang Z, Yang M. Molecular network of colorectal cancer and current therapeutic options. Front Oncol. 2022, 12:852927. 10.3389\/fonc.2022.852927","journal-title":"Front Oncol"},{"key":"ref5","unstructured":"Centers for Disease Control and Prevention. Colorectal cancer risk factors. (2024). https.\/\/www.cdc.gov\/colorectal-cancer\/risk-factors\/index.html."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2017.11.041","article-title":"High risk of anal and rectal cancer in patients with anal and\/or perianal Crohn\u2019s disease","volume":"16","author":"Beaugerie L","year":"2018","unstructured":"Beaugerie L, Carrat F, Nahon S, et al.. High risk of anal and rectal cancer in patients with anal and\/or perianal Crohn\u2019s disease. Clin Gastroenterol Hepatol. 2018, 16:892-9.e2. 10.1016\/j.cgh.2017.11.041","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-0275-y","article-title":"The multidisciplinary management of rectal cancer","volume":"17","author":"Keller DS","year":"2020","unstructured":"Keller DS, Berho M, Perez RO, Wexner SD, Chand M. The multidisciplinary management of rectal cancer. Nat Rev Gastroenterol Hepatol. 2020, 17:414-29. 10.1038\/s41575-020-0275-y","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2024.0041","article-title":"NCCN Guidelines\u00ae Insights: rectal cancer, version 3.2024","volume":"22","author":"Benson AB","year":"2024","unstructured":"Benson AB, Venook AP, Adam M, et al.. NCCN Guidelines\u00ae Insights: rectal cancer, version 3.2024. J Natl Compr Canc Netw. 2024, 22:366-75. 10.6004\/jnccn.2024.0041","journal-title":"J Natl Compr Canc Netw"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-017-2765-0","article-title":"Functional outcome following rectal surgery\u2014predisposing factors for low anterior resection syndrome","volume":"32","author":"Hughes DL","year":"2017","unstructured":"Hughes DL, Cornish J, Morris C. Functional outcome following rectal surgery\u2014predisposing factors for low anterior resection syndrome. Int J Colorectal Dis. 2017, 32:691-7. 10.1007\/s00384-017-2765-0","journal-title":"Int J Colorectal Dis"},{"key":"ref10","unstructured":"A bioelectronic approach to post-surgical anastomotic leakage diagnosis. (2021). https.\/\/stax.strath.ac.uk\/concern\/theses\/73666480p."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-023-04534-2","article-title":"Oncologic outcomes of watch-and-wait strategy or surgery for low to intermediate rectal cancer in clinical complete remission after adjuvant chemotherapy: a systematic review and meta-analysis","volume":"38","author":"Tan S","year":"2023","unstructured":"Tan S, Gao Q, Cui Y, Ou Y, Huang S, Feng W. Oncologic outcomes of watch-and-wait strategy or surgery for low to intermediate rectal cancer in clinical complete remission after adjuvant chemotherapy: a systematic review and meta-analysis. Int J Colorectal Dis. 2023, 38:246. 10.1007\/s00384-023-04534-2","journal-title":"Int J Colorectal Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000002447","article-title":"Organ preservation in cT2N0 rectal cancer after neoadjuvant chemoradiation therapy: the impact of radiation therapy dose-escalation and consolidation chemotherapy","volume":"269","author":"Habr-Gama A","year":"2019","unstructured":"Habr-Gama A, S\u00e3o Juli\u00e3o GP, Vailati BB, et al.. Organ preservation in cT2N0 rectal cancer after neoadjuvant chemoradiation therapy: the impact of radiation therapy dose-escalation and consolidation chemotherapy. Ann Surg. 2019, 269:102-7. 10.1097\/SLA.0000000000002447","journal-title":"Ann Surg"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00467-2","article-title":"Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis","volume":"17","author":"Renehan AG","year":"2016","unstructured":"Renehan AG, Malcomson L, Emsley R, et al.. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis. Lancet Oncol. 2016, 17:174-83. 10.1016\/S1470-2045(15)00467-2","journal-title":"Lancet Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-021-01746-0","article-title":"The watch-and-wait strategy versus surgical resection for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy","volume":"16","author":"Wang QX","year":"2021","unstructured":"Wang QX, Zhang R, Xiao WW, et al.. The watch-and-wait strategy versus surgical resection for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy. Radiat Oncol. 2021, 16:16. 10.1186\/s13014-021-01746-0","journal-title":"Radiat Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.suronc.2021.101574","article-title":"Rectal cancer: watch-and-wait and continuing the rectal-preserving strategy with local excision for incomplete response or limited regrowth","volume":"37","author":"Al-Najami I","year":"2021","unstructured":"Al-Najami I, Jones HJ, Dickson EA, Muirhead R, Deding U, James DR, Cunningham C. Rectal cancer: watch-and-wait and continuing the rectal-preserving strategy with local excision for incomplete response or limited regrowth. Surg Oncol. 2021, 37:101574. 10.1016\/j.suronc.2021.101574","journal-title":"Surg Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-021-02415-y","article-title":"A meta-analysis of the watch-and-wait strategy versus total mesorectal excision for rectal cancer exhibiting complete clinical response after neoadjuvant chemoradiotherapy","volume":"19","author":"Yu G","year":"2021","unstructured":"Yu G, Lu W, Jiao Z, Qiao J, Ma S, Liu X. A meta-analysis of the watch-and-wait strategy versus total mesorectal excision for rectal cancer exhibiting complete clinical response after neoadjuvant chemoradiotherapy. World J Surg Oncol. 2021, 19:305. 10.1186\/s12957-021-02415-y","journal-title":"World J Surg Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000002761","article-title":"Oncological and survival outcomes in watch and wait patients with a clinical complete response after neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and pooled analysis","volume":"268","author":"Dattani M","year":"2018","unstructured":"Dattani M, Heald RJ, Goussous G, et al.. Oncological and survival outcomes in watch and wait patients with a clinical complete response after neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and pooled analysis. Ann Surg. 2018, 268:955-67. 10.1097\/SLA.0000000000002761","journal-title":"Ann Surg"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.suronc.2022.101774","article-title":"Watch and wait: why, to whom and how","volume":"43","author":"Cerd\u00e1n-Santacruz C","year":"2022","unstructured":"Cerd\u00e1n-Santacruz C, Vailati BB, S\u00e3o Juli\u00e3o GP, Habr-Gama A, Perez RO. Watch and wait: why, to whom and how. Surg Oncol. 2022, 43:101774. 10.1016\/j.suronc.2022.101774","journal-title":"Surg Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30557-X","article-title":"Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study","volume":"22","author":"Fernandez LM","year":"2021","unstructured":"Fernandez LM, S\u00e3o Juli\u00e3o GP, Figueiredo NL, et al.. Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study. Lancet Oncol. 2021, 22:43-50. 10.1016\/S1470-2045(20)30557-X","journal-title":"Lancet Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1632-z","article-title":"Organ preservation in rectal adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management","volume":"15","author":"Smith JJ","year":"2015","unstructured":"Smith JJ, Chow OS, Gollub MJ, et al.. Organ preservation in rectal adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management. BMC Cancer. 2015, 15:767. 10.1186\/s12885-015-1632-z","journal-title":"BMC Cancer"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(18)30301-7","article-title":"Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis","volume":"3","author":"Chadi SA","year":"2018","unstructured":"Chadi SA, Malcomson L, Ensor J, et al.. Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis. Lancet Gastroenterol Hepatol. 2018, 3:825-36. 10.1016\/S2468-1253(18)30301-7","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/DCR.0b013e3182a586e7","article-title":"The impact of age on colorectal cancer incidence, treatment, and outcomes in an equal-access health care system","volume":"57","author":"Steele SR","year":"2014","unstructured":"Steele SR, Park GE, Johnson EK, Martin MJ, Stojadinovic A, Maykel JA, Causey MW. The impact of age on colorectal cancer incidence, treatment, and outcomes in an equal-access health care system. Dis Colon Rectum. 2014, 57:303-10. 10.1097\/DCR.0b013e3182a586e7","journal-title":"Dis Colon Rectum"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.11779","article-title":"Advanced age is a risk factor for recurrence after resection in stage II colorectal cancer","volume":"34","author":"Mima K","year":"2020","unstructured":"Mima K, Kurashige J, Miyanari N, et al.. Advanced age is a risk factor for recurrence after resection in stage II colorectal cancer. In Vivo. 2020, 34:339-46. 10.21873\/invivo.11779","journal-title":"In Vivo"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/jso.26913","article-title":"Is increasing nodal count associated with improved recurrence-free and overall survival following standard right hemicolectomy for colon cancer?","volume":"126","author":"Hayes IP","year":"2022","unstructured":"Hayes IP, Milanzi E, Gibbs P, Faragher I, Reece JC. Is increasing nodal count associated with improved recurrence-free and overall survival following standard right hemicolectomy for colon cancer?. J Surg Oncol. 2022, 126:523-34. 10.1002\/jso.26913","journal-title":"J Surg Oncol"},{"key":"ref25","article-title":"Histological grade predicts survival time associated with recurrence after resection for colorectal cancer","volume":"56","author":"Cho YB","year":"2009","unstructured":"Cho YB, Chun HK, Yun HR, Kim HC, Yun SH, Lee WY. Histological grade predicts survival time associated with recurrence after resection for colorectal cancer. Hepatogastroenterology. 2009, 56:1335-40.","journal-title":"Hepatogastroenterology"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-022-02064-9","article-title":"Postoperative locoregional recurrence pattern and treatment management of stage pT4 sigmoid colon cancer: a retrospective cohort study","volume":"17","author":"Lin Y","year":"2022","unstructured":"Lin Y, Liu S, Hong L, Shao L, Wu J. Postoperative locoregional recurrence pattern and treatment management of stage pT4 sigmoid colon cancer: a retrospective cohort study. Radiat Oncol. 2022, 17:95. 10.1186\/s13014-022-02064-9","journal-title":"Radiat Oncol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1177\/1724600818820679","article-title":"Serum carcinoembryonic antigen to predict recurrence in the follow-up of patients with colorectal cancer","volume":"34","author":"Ramphal W","year":"2019","unstructured":"Ramphal W, Boeding JR, van Iwaarden M, Schreinemakers JM, Rutten HJ, Crolla RM, Gobardhan PD. Serum carcinoembryonic antigen to predict recurrence in the follow-up of patients with colorectal cancer. Int J Biol Markers. 2019, 34:60-8. 10.1177\/1724600818820679","journal-title":"Int J Biol Markers"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/274449-outcomes-of-watch-and-wait-versus-abdominoperineal-resection-in-lower-rectal-adenocarcinoma-post-neoadjuvant-therapy-an-iraqi-cohort-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T18:01:01Z","timestamp":1724781661000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/274449-outcomes-of-watch-and-wait-versus-abdominoperineal-resection-in-lower-rectal-adenocarcinoma-post-neoadjuvant-therapy-an-iraqi-cohort-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,27]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.67955","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,27]]}}}